Kangwei Bio

Kangwei Bio

康威生物

Kangwei Bio

Biotech/Healthcare

Kangwei Biotech is focused on developing a new class of drugs, including anticancer drugs and innovative treatments for infertility. Its core team consists of overseas-trained PhDs with independent intellectual property.

Latest round: Series A Extension (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-08-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.